Despite these potential risks, clinical study of FAAH inhibitors for the potential treatment of human diseases is awaited with great anticipation.Although this review is mostly focused on the processes that mediated endocannabinoid metabolism in the nervous system, where FAAH appears to play a principal role in anandamide degradation, it should be stressed that other enzymes, such as FAAH-2 and NA